Baker McKenzie Makes a Life Sciences Play

The firm is building its healthcare & pharma practice on the East Coast

The firm is building its healthcare & pharma practice on the East Coast

Randall Sunberg, former co-chair of Morgan, Lewis & Bockius’s life sciences department, left for Baker McKenzie this week; he was joined by corporate and securities expert Denis Segota. Though technically belonging to the firm’s New York office, both partners will be working in Princeton, New Jersey – a state that employs over 117,000 people in the life sciences industry.


Life sciences contribute $47.5bn to New Jersey’s economy every year; indeed, the Garden State is home to the key operation facilities of 12 of the world’s top 20 biopharmaceutical companies. The sector is spanned comprehensively in the area, from drugs and pharmaceuticals to medical devices to distribution, and so it makes sense for law firms making healthcare and life sciences plays to strengthen their base there, as well as in the so-called “life sciences corridor” in Massachusetts. Indeed, we covered this trend here last month.


Sunberg, who will be co-heading Baker McKenzie’s North America life sciences department, has longstanding expertise in assisting a range of clients in the sector with commercial and financing matters. Sunberg and M&A and financing expert Segota both cited their new firm’s expertise in emerging markets as a key reason for their move. “Our pharmaceutical clients are focusing on growth and they’re looking at emerging markets for [that] growth,” said Segota.


Another reason was Baker McKenzie’s industry focus. The firm fields hundreds of lawyers around the world who advise healthcare, biotech and pharmaceuticals companies on the full range of legal matters, and while it may not rank among the very top healthcare & life sciences dealmakers in the US by volume or value, its global platform, strength in depth and breadth of service within the healthcare and life sciences sector are undeniable.

Read the full Special Report: USA: Global Powerhouse

In a world where the only thing that doesn't change is change itself, opportunities and risks are too obvious to ignore, and the legal market is no exception. Worth over $400 billion and one of the most profitable in the world, the U.S. legal industry is under fundamental transformation. Whether you're an in-house counsel or a law firm, only those with far-ranging sights, clear thoughts and quick action can survive and thrive.
Summary Heroes & Zeros: Anthony Fauci Analysis: Star dealmaker Edward Lee leaves Wachtell for Kirkland Fed expands lending programme to reach more businesses "Sellers considering a sale or financing should begin the process now" Analysis: King & Spalding wins big from Boies Schiller defections Heroes and Zeros: Donald Trump Analysis: SoftBank pulls out of $3bn WeWork investment US Navy Captain fired for coronavirus letter Johnson & Johnson secures $456m for coronavirus therapy Winston & Strawn hires three healthcare partners in D.C.
Summary Orrick, Herrington & Sutcliffe Opens an Office in Boston Sidley Austin Starts 2019 With Corporate & Finance Hires Hogan Lovells makes another restructuring hire in New York US legal news round-up: 26-30 November 2018 BakerHostetler launches new Investment Funds team Pierce Bainbridge Continues Rapid Expansion Incubating talent, incentivizing teamwork Antitrust expert Vishal Mehta joins Morrison & Foerster Knobbe Martens opens office in NYC


Accenture's CEO and CFO interview by Leaders League Group

About us